UT San Antonio
UT Health San Antonio
210-567-7000 Give
Category ID
171

Healio: Momelotinib superior to danzol in symptomatic and anemic myelofibrosis

<p>Dr. Ruben Mesa, Mays Cancer Center, is quoted in this article. &nbsp; Read More</p>

Share This Story

Mays Cancer Center receives grants, continued support from American Cancer Society

<p>Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO (June 13, 2022) – In late April, American Cancer Society (ACS) awarded the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, two check donations in the amounts of $480,000 for an institutional research grant and $65,000 for cancer support grants. Both checks were [&hellip;]</p>

Share This Story

ASCO Post: Momelotinib for Symptomatic and Anemic Patients With Myelofibrosis

<p>Dr. Ruben Mesa, Mays Cancer Center, is quoted in this article. &nbsp; Read More</p>

Share This Story

San Antonio Business Journal: The new cancer quest and what it means for San Antonio

<p>Drs. Ruben Mesa, Kate Lathrop and Mark Bonnen of the Mays Cancer Center took part in a panel discussion for this story. &nbsp; Read More</p>

Share This Story

Mays Cancer Center featured for its value to the region’s population and economy

<p>In a special section of the June 17, 2022, San Antonio Business Journal, experts from Mays Cancer Center at UT Health San Antonio discuss the broad scope of cancer patient care and lifesaving research taking place daily at the center and its value to the local community and regional economy.</p>

Share This Story

KSAT 12: Black women die of breast cancer at rates nearly 40% higher than white women, local researcher finds in new study

<p>Dr. Ismail Jatoi, Mays Cancer Center, was interviewed for this story about his recently published study. &nbsp; Read More</p>

Share This Story

Mays Cancer Center executive director testifies before House panel about clinical trial diversity

<p>Ruben A. Mesa, MD, FACP, professor of medicine and executive director of the Mays Cancer Center at UT Health San Antonio, testified on clinical trial diversity yesterday (March 17, 2022) before the House Committee on Energy and Commerce. The hearing was titled “The Future of Medicine: Legislation to Encourage Innovation and Improve Oversight.” Dr. Mesa [&hellip;]</p>

Share This Story

San Antonio Business Journal: Delayed by pandemic, construction on $62M cancer center could start this year

<p>Ruben Mesa, MD, FACP, executive director of Mays Cancer Center at UT Health San Antonio, is quoted in this story about the city’s support of a new proton therapy center, a partnership between the institution and Proton International. &nbsp; Read More</p>

Share This Story

San Antonio Business Journal: UT Health San Antonio lands nearly $11M in cancer research funding

<p>Dr. Gail Tomlinson, Dr. Masahiro Morita, Dr. Alexei Tumanov, Dr. Reuben Harris, Dr. Robert Hromas and Dr. Patrick Sung are quoted or mentioned in this article. &nbsp; Read More</p>

Share This Story

CPRIT adds $10.9 million to UT Health San Antonio cancer research and prevention efforts

<p>UT Health San Antonio is receiving $10.9 million in new research and faculty recruitment awards announced Feb. 16 by the Cancer Prevention and Research Institute of Texas (CPRIT). The statewide cancer agency has now awarded $128.7 million to UT Health San Antonio since 2010. A five-year, $6 million CPRIT Recruitment of Established Investigators award — [&hellip;]</p>

Share This Story

Subscribe to Cancer